Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients

Joanna Wawryka; Ewa Barg

Full text

2/2016 vol. 22

Review paper

Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients

Joanna Wawryka

,

Ewa Barg

Pediatr Endocrinol Diabetes Metab 2016;22,2:60-65

Data publikacji online: 2017/03/20

Article file

a_36592.pdf

AMA

Wawryka J, Barg E. Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(2).

APA

Wawryka, J., & Barg, E. (2016). Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism, 22(2).

Chicago

Wawryka, Joanna, and Ewa Barg. 2016. "Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients". Pediatric Endocrinology Diabetes and Metabolism 22 (2).

Harvard

Wawryka, J., and Barg, E. (2016). Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism, 22(2).

MLA

Wawryka, Joanna et al. "Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients." Pediatric Endocrinology Diabetes and Metabolism, vol. 22, no. 2, 2016.

Vancouver

Wawryka J, Barg E. Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(2).

SUBMIT YOUR PAPER

Share

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications